<DOC>
	<DOCNO>NCT01039389</DOCNO>
	<brief_summary>The purpose study patient chronic stable coronary artery disease treatable percutaneous coronary intervention ( PCI ) evaluate long-term efficacy safety orally take selective I ( f ) -inhibitor Ivabradine ( ProcoralanÂ® , Servier Switzerland ) regard promotion collateral growth .</brief_summary>
	<brief_title>Promotion Coronary Collateral Function Ivabradine-Induced Bradycardia Patients With Coronary Artery Disease</brief_title>
	<detailed_description>Coronary artery disease ( CAD ) lead cause death industrialized country . Current therapy restoration coronary flow percutaneous coronary intervention ( PCI ) surgical revascularization . However , inherent procedure-related risk fact CAD progression prevent . Additionally , one fourth CAD patient amenable standard revascularization therapy . Thus , need alternative therapy . Coronary collateral natural bypass anastomose without intervene capillary bed portion coronary artery different coronary artery . The coronary collateral circulation prevalent human CAD amount collateral flow directly relate infarct size , all-cause- cardiac mortality . Thus , goal promote collateral function sense prophylactic myocardial salvage . Coronary ( collateral ) blood flow occur almost entirely diastole . Fluid shear stress ( FSS ) drive force formation , promotion maintenance collateral ( i.e . arteriogenesis ) . It product blood viscosity shear rate , latter fluid velocity change different fluid layer related fluid velocity endothelium . Prolongation diastole via reduction rest heart rate ( RHR ) naturally equal extension shear stress endothelium . Bradycardia likely key factor augment collateral function : In several animal model , inverse relation heart rate collateral function find . We recently confirm find investigate collateral function measurement normal coronary artery patient population . The fact beta blocker depress contractility unmask beta-adrenergic coronary vasoconstriction prompt development selective I ( f ) -inhibitors . To date , ivabradine clinically available specific inhibitor pacemaker current sinuatrial node ( call `` funny '' current , permeability mixed ion activation hyperpolarization instead depolarization , I ( f ) ) . It act pure heart rate lower agent without affect blood pressure , myocardial contractility , intra-cardiac conduction , ventricular repolarization . In contrast beta blocker calcium channel blocker , mimic physiological bradycardia therefore appropriate purpose study . By bradycardization CAD , ischemia target via reduction myocardial oxygen demand increase oxygen supply without negative inotropic , coronary vasoconstrictive , metabolic effect . In term anti-anginal efficacy , ivabradine find effective atenolol amlodipine .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>1 . Age &gt; 18 year old 2 . 1 3vessel stable coronary artery disease ( CAD ) 3 . At least 1 stenotic lesion suitable PCI 4 . No Qwave myocardial infarction area undergo CFI measurement 5 . Written inform consent participate study 1 . Acute coronary syndrome 2 . CAD treat best surgical coronary bypass 3 . Indications BB treatment ( heart failure , arrhythmia , &lt; 3months postinfarct ) 4 . RHR &lt; 60/min without treatment 5 . Sick sinus syndrome , sinuatrial block &gt; 2nd degree atrioventricular block 6 . Atrial fibrillation 7 . Inherited acquire longQT syndrome 8 . Indwelling pacemaker 9 . Severe hepatic renal failure ( creatinine clearance &lt; 15ml/min ) 10 . Hypersensitivity ivabradine adjuvant 11 . Premenopausal woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Stable</keyword>
	<keyword>Coronary Collaterals</keyword>
	<keyword>Therapeutic Collateral Promotion</keyword>
	<keyword>Arteriogenesis</keyword>
	<keyword>Bradycardia</keyword>
</DOC>